NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Uhlig K, Balk EM, Patel K, et al. Self-Measured Blood Pressure Monitoring: Comparative Effectiveness [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jan. (Comparative Effectiveness Reviews, No. 45.)
Table D-1. Information on SMBP device accreditation (MS Word, 116K)
Table D-2. Description of study interventions: Key Question 1 (MS Word, 119K)
Table D-3. Study characteristics: Key Question 1 (MS Word, 119K)
Table D-4. Categorical BP: SMBP alone versus usual care (MS Word, 83K)
Table D-5. Clinic BP: SMBP alone versus usual care (MS Word, 94K)
Table D-6. Ambulatory BP, 24 hour: SMBP alone versus usual care (MS Word, 73K)
Table D-7. Ambulatory BP, awake: SMBP alone versus usual care (MS Word, 74K)
Table D-8. Ambulatory BP, asleep: SMBP alone versus usual care (MS Word, 73K)
Table D-9. Categorical medication dose and number outcomes: SMBP alone versus usual care (MS Word, 73K)
Table D-10. Continuous medication dose and number outcomes: SMBP alone versus usual care (MS Word, 72K)
Table D-11. Categorical medication adherence: SMBP alone versus usual care (MS Word, 71K)
Table D-12. Continuous medication adherence: SMBP alone versus usual care (MS Word, 69K)
Table D-13. Quality of life: SMBP alone versus usual care (MS Word, 71K)
Table D-14. Categorical health care resource use: SMBP alone versus usual care (MS Word, 66K)
Table D-15. Continuous health care resource use: SMBP alone versus usual care (MS Word, 73K)
Table D-16. Continuous miscellaneous outcomes: SMBP alone versus usual care (MS Word, 67K)
Table D-17. Categorical BP: SMBP plus additional support versus usual care (MS Word, 84K)
Table D-18. Clinic BP: SMBP plus additional support versus usual care (MS Word, 107K)
Table D-19. Ambulatory BP: SMBP plus additional support versus usual care (MS Word, 70K)
Table D-20. Categorical medication dose and number outcomes: SMBP plus additional support versus usual care (MS Word, 74K)
Table D-21. Continuous medication dose and number outcomes: SMBP plus additional support versus usual care (MS Word, 77K)
Table D-22. Categorical medication adherence: SMBP plus additional support versus usual care (MS Word, 69K)
Table D-23. Continuous medication adherence: SMBP plus additional support versus usual care (MS Word, 72K)
Table D-24. Quality of life: SMBP plus additional support versus usual care (MS Word, 73K)
Table D-25. Continuous health care resource use: SMBP plus additional support versus usual care (MS Word, 80K)
Table D-26. Categorical miscellaneous outcomes: SMBP plus additional support versus usual care (MS Word, 66K)
Table D-27. Description of study interventions: Key Question 2 (MS Word, 83K)
Table D-28. Study characteristics: Key Question 2 (MS Word, 83K)
Table D-29. Categorical BP: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 78K)
Table D-30. Clinic BP: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 81K)
Table D-31. Ambulatory BP: SMBP plus additional support versus SMBP alone (or with other additional support) (MS Word, 67K)
Table D-32. Quality of life: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 70K)
Table D-35. Categorical medication adherence: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 68K)
Table D-36. Continuous medication adherence: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 66K)
Table D-37. Categorical health care resource use: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 66K)
Table D-38. Continuous health care resource use: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 77K)
Table D-39. Continuous miscellaneous outcomes: SMBP plus additional support versus SMBP alone (or other additional support) (MS Word, 66K)
Table D-40. Categorical BP: Atypical studies (MS Word, 67K)
Table D-41. Continuous BP: Atypical studies (MS Word, 72K)
Table D-42. Non-BP continuous outcomes: Atypical studies (MS Word, 69K)
Table D-43. Categorical non-BP outcomes: Atypical studies (MS Word, 67K)
Table D-44. Ongoing research on SMBP identified through ClinicalTrials.gov (MS Word, 71K)
- Additional Tables - Self-Measured Blood Pressure Monitoring: Comparative Effecti...Additional Tables - Self-Measured Blood Pressure Monitoring: Comparative Effectiveness
- Levilactobacillus fuyuanensis strain CCM 8906 spades_K_17_127_45, whole genome s...Levilactobacillus fuyuanensis strain CCM 8906 spades_K_17_127_45, whole genome shotgun sequencegi|2821119225|ref|NZ_JBHTOM01000004 gnl|WGS:NZ_JBHTOM01|spades_K_17_127_45Nucleotide
- Corynebacterium sp. MSK004 NODE_12_length_65762_cov_36.101180, whole genome shot...Corynebacterium sp. MSK004 NODE_12_length_65762_cov_36.101180, whole genome shotgun sequencegi|2519150469|ref|NZ_JASPKB01000001 gnl|WGS:NZ_JASPKB01|NODE_12_length_65762_cov_36.101180Nucleotide
- List of Abbreviations - Comparative Effectiveness, Safety, and Indications of In...List of Abbreviations - Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes
- Receptor-type guanylate cyclase gcy-28 [Caenorhabditis elegans]Receptor-type guanylate cyclase gcy-28 [Caenorhabditis elegans]gi|1972228306|ref|NP_001380039.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...